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Abstract
Background: Enzymes belonging to the same super family of proteins in general operate on variety of substrates
and are inhibited by wide selection of inhibitors. In this work our main objective was to expand the scope of
studies that consider only the catalytic and binding pocket amino acids while analyzing enzyme specificity and
instead, include a wider category which we have named the Interface Forming Residues (IFR). We were motivated
to identify those amino acids with decreased accessibility to solvent after docking of different types of inhibitors to
sub classes of serine proteases and then create a table (matrix) of all amino acid positions at the interface as well
as their respective occupancies. Our goal is to establish a platform for analysis of the relationship between IFR
characteristics and binding properties/specificity for bi-molecular complexes.
Results: We propose a novel method for describing binding properties and delineating serine proteases specificity
by compiling an exhaustive table of interface forming residues (IFR) for serine proteases and their inhibitors.
Currently, the Protein Data Bank (PDB) does not contain all the data that our analysis would require. Therefore, an
in silico approach was designed for building corresponding complexes
The IFRs are obtained by “rigid body docking” among 70 structurally aligned, sequence wise non-redundant, serine
protease structures with 3 inhibitors: bovine pancreatic trypsin inhibitor (BPTI), ecotine and ovomucoid third
domain inhibitor. The table (matrix) of all amino acid positions at the interface and their respective occupancy is
created. We also developed a new computational protocol for predicting IFRs for those complexes which were not
deciphered experimentally so far, achieving accuracy of at least 0.97.
Conclusions: The serine proteases interfaces prefer polar (including glycine) residues (with some exceptions).
Charged residues were found to be uniquely prevalent at the interfaces between the “miscellaneous-virus”
subfamily and the three inhibitors. This prompts speculation about how important this difference in IFR
characteristics is for maintaining virulence of those organisms.
Our work here provides a unique tool for both structure/function relationship analysis as well as a compilation of
indicators detailing how the specificity of various serine proteases may have been achieved and/or could be
altered. It also indicates that the interface forming residues which also determine specificity of serine protease sub-
family can not be presented in a canonical way but rather as a matrix of alternative populations of amino acids
occupying variety of IFR positions.
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Serine proteases play an important role in processes such
as blood clotting, digestion and in some pathways of cell
development [1]. Serine proteases can hydrolyze either
peptide bonds or esters. Proteases digest proteins by
hydrolyzing the peptide bonds which are responsible for
keeping amino acids together [2,3]. The cleavage specifi-
city of elastase, trypsin, chymotrypsin and other serine
proteases depends on the volume/size, form/shape, and
polarity/charge/hydrophobicity of the specific part of a
protein surface where a substrate will be docking - the
specificity pocket [4,5]. There are three amino acid resi-
dues responsible for the enzymatic activity that are present
in all serine proteases, which are denominated as the cata-
lytic triad: His 57, Asp 102 and Ser 195 (chymotrypsin
numbering system is used throughout - see [6]). Interest-
ingly, out of those three amino acids, only Asp 102 does
not make part of the interface (the definition of which is
based on decreased solvent accessible area upon substrate/
inhibitor binding). This is due to the fact that Asp 102 is
already not accessible to solvent in isolated enzyme,
because this amino acid is located at the very bottom of
the active site cleft where solvent molecules (water) can
not access it. The role of the first two amino acids (His 57
and Asp 102) during trypsin catalysis, for example, is to
function as a proton shuttle. Trypsin cleaves peptides after
Lys and Arg residues with the co-participation of Asp 189,
which interacts with the positive charge on peptide [7,8].
Chymotrypsin, on the other hand, cleaves proteins after
aromatic (and also large hydrophobic) residues [9]. To
achieve such specificity, in chymotrypsin, one can easily
identify the existence of the hydrophobic pocket, normally
shielded by Met 192. Thrombin is a protease which
cleaves peptides with more specificity than trypsin: it
requires Arg on “P1” position [10,11]. Our main objective
in this work is to expand the scope of studies that analyze
enzyme specificity by including into observations not only
the catalytic triad and binding pocket but also a wider
category of amino acids which we have named the Inter-
face Forming Residues (IFR) [12-15]. Namely, only a part
of the molecular surface is shielded from solvent upon for-
mation of a bi-molecular complex. The residues having a
lower accessibility to solvent upon complex formation
have an important role in the process of docking and also
in defining specificity [15,16]. Therefore, we were moti-
vated to calculate which amino acids are shielded from
solvent in the bi-molecular complexes involving serine
proteases and different types of inhibitors and then create
a table (matrix) of all amino acid positions at the interface
and their respective occupancies. By mapping those amino
acids as a specific IFR, we are now able to analyze charac-
teristics of each position; and by doing so, we also can
make position-specific alignment among different
subfamilies of serine proteases. The key step we needed to
solve during our procedural approach was to find a suffi-
cient number of PDB [17] structures containing complexes
of serine proteases with respective inhibitors. It became
clear that we would need to either produce those by some
novel method or abandon our work because there were
not enough samples available in the PDB. The solution to
this challenge is presented in details in materials and
methods.
Results
Interface Forming Residue (IFR) tables
In order to provide a sufficient volume of data for analy-
sis of the interfaces around active sites of serine pro-
teases (even though there is no enough structural
information available currently on complexes formed by
one particular protease with any specific substrate and/
or inhibitor) we needed to employ the in silico approach
for building corresponding complexes. The key feature
of our work is mapping the IFR 3D profile into a 2D
matrix–from a known enzyme-inhibitor structure to
those with no known structure for such complex. Map-
ping is done after structurally aligning all serine pro-
teases with non-redundant sequences.
After selection of 67 serine protease structural files (in
a way described in materials and methods), named here
as a secondary datamart, and three prototype complexes,
containing inhibitor/serine protease complexes, we
ended up with total of 70 structures with non redundant
enzyme sequences. The list of all corresponding PDB
IDs for serine proteases used in this work is presented
in the Table 1. All selected 70 serine proteases were
Table 1 List of all PDB files containing serine protease
structures used for structural alignment
01-1LTO 02-2FPZ 03-1NN6 04-3RP2 05-1K2I
06-1EQ9 07-1GCT 08-1PYT 09-1ELT 10-1M9U
11-1HNE 12-1GVK 13-1BRU 14-1AGJ 15-1QTF
16-1HPG 17-2O8L 18-1P3C 19-2PKA 20-1GVZ
21-1LO6 22-1TON 23-2FOM 24-2FP7 25-1DY9
26-2SGA 27-1SGP 28-1PQ7 29-1TRN 30-1HJ9
31-1HJ8 32-2F91 33-1H4W 34-2A31 35-1A0J
36-1OS8 37-1OP0 38-1BQY 39-1C5L 40-1VR1
41-2PUX 42-1H8D 43-1ETR 44-1ARB 45-1Y8T
46-2SFA 47-1SOT 48-2H5C 49-1NPM 50-1EP5
51-1FIW 52-1DLE 53-1T32 54-2BZ6 55-1BIO
56-1EUF 57-1EKB 58-1IAU 59-2HLC 60-1Q3X
61-1EAX 62-1FUJ 63-1MBM 64-1FON 65-1RTF
66-1C5Y 67-1A7S 68-1FY8 69-1AZZ 70-1CHO
The last three PDB IDs (underlined) contain a description of the native
complexes of: anionic trypsinogen with BPTI, collagenase with Ecotin and
alpha-chymotrypsin with Ovomucoid, respectively.
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Page 2 of 16then structurally aligned. Upon rigid body docking of
the three different inhibitors to 67 serine proteases from
the secondary datamart, we constructed complexes
which, counting also the three prototype ones, totalled
to three sets of 70 two-chain macromolecules. The
interfaces for those three sets were calculated using
SurfV program [18] and for each in silico generated
complex, we mapped all of the sequence positions
that belonged to IFR ensemble into the table shown at
Figure 1.
Analysis of the tabulated IFR data (as presented in the
Figure 1) clearly indicates subfamily differences with
respect to characteristics, position and frequency of
occupancy of interface residues. The data compiled here
can be used as an additional tool for characterizing
function and specificity. This is particularly relevant for
planning structure/sequence changes intended to alter
protein activity, e.g., from trypsin to chymotrypsin type
activity. More generally, one subfamily type of serine
protease can be adjusted to behave like another if corre-
sponding changes are made in an initial protease
sequence. Attempts have been made to alter protein
activity [4,19], but they have focused on a single or, at
most, 5 to10 residues. Our data, shown on Figure 1,
indicate that such alterations can be achieved by elimi-
nating key differences in IFR occupancy.
In case of trypsin, chymotrypsin, elastase and throm-
bin, each bound to BPTI, differences are present at 36
IFR positions (presented in the table shown at Figure 2).
In the table shown at Figure 3, for instance, sequence
position 40 is occupied by His (in chymotrypsin and
elastase exclusively, and in trypsin mainly) or hydropho-
bic residues (in thrombins exclusively). Position 172
(across all 4 subfamilies) is occupied by mostly polar
residues (with some hydrophobic residues present in
elastase case). Positions 94, 215 and 216 are occupied by
mostly polar residues in at least 3 subfamilies.
In general, positions were designated as “Ph” if they
were occupied by mostly (present in at least 50% of
complexes) Polar and occasionally some hydrophobic
residues. Similarly, IFR positions occupied by only
Charged residues were marked as “C“,t h o s ew i t ho n l y
Polar residues as “P“ and those occupied by only
Hydrophobic residues as “H“. A combination of letters
would mean presence of residues belonging to multiple/
distinct amino acid classes. Capital letters are used to
designate a predominant residue presence (again, pre-
sent in at least 50% of complexes analysed) while small
letters designate an occasional presence.
There are less restrictive positions which can be occu-
pied by different classes of amino acids in either one
sub family (such as position 143 and 175) or across all
subfamilies (positions 37, 60, 96, 97, 192 and 224). A
specific analysis of the positi o n9 7 ,s h o w st h a ti ti sl e s s
restrictive for trypsins (positively charged: K, R; polar:
N, Y; negatively charged: D) and elastases (polar: N;
negatively charged: D; hydrophobic: V) than for chymo-
trypsins (hydrophobic: L, F) and thrombins (positively
charged: R).
In order to additionally facilitate analysis of the data at
Figures 2, 3 and 4, we have labelled with the gray back-
ground color those IFR positions which are populated,
w i t h i nas u b f a m i l y ,b yas i n g l er e s i d u et y p eo ra r ea b s e n t
from the IFR ensemble (represented by “-”). It is impor-
tant to realize that the presence of one type of amino
acid per subfamily is treated here in a same fashion as
the absence of that particular position from the IFR
ensemble because we understand that the event we call
“no-show” for particular position is equally information
dense as the information on type of occupancy for parti-
cular IFR position. Those IFR positions occupied in each
one of four sub families by one predominant type of
amino acid, present in at least 50% of serine proteases
showing this particular IFR, marked here with the “*”, are
labelled in light gray. Therefore, the analysis of Figures 2,
3 and 4 is aided by four distinct labels: 1) residue “amino-
chromography”, 2) dark gray background, 3) light grey
background and 4) “occupancy type”. The fourth label is
present in the last column and indicates the two predo-
minant residue classes present in the preceding 4 col-
umns (four serine protease subfamilies). Similar analysis
was done for two other inhibitors: BPTI with 36 identi-
fied IFR positions at the enzyme side (Figure 2), and ovo-
mucoid third domain with 34 identified IFR positions at
the enzyme side (the table shown at Figure 4).
From the data presented in Figures 2 and 4 (restrictive
IFR positions of complexes formed with BPTI and ovo-
mucoid third domain inhibitors, respectively) IFR loca-
tions 94 and 172 are shown to contain only polar
residues (no presence of hydrophobic residues was
found in contrast to the same locations in the Figure 3).
By comparing the data from the figures 2, 3 and 4, the
complexes of serine proteases with ecotine inhibitor
compile 13 restrictive (gray), 10 half-restrictive (light
gray) and 17 non-restrictive IFR positions (total: 40
positions). In the case of the BPTI and ovomucoid inhi-
bitors, respective data are: 14, 7 and 15 (36); 11, 7 and
16 (34). Those numbers indicate that ecotine binding to
serine proteases involves 32.5% restrictive, 25% less
restrictive and 42.5% non restrictive IFR positions while
BPTI and ovomucoid show respectively: 39%, 19.5% and
41.5%; 32%, 20.5% and 47%. Consequently, these num-
bers show that the ovomucoid inhibitor binding to ser-
ine proteases is less specific than the binding of ecotine,
which in turn is less specific than BPTI. The experimen-
tal Ki [M] values reported in the literature for BPTI
against trypsin is 6 × 10
-14 while for the chymotrypsin it
goes down to 9 × 10
-9 and for elastase to 3.5 × 10
-6
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Page 3 of 16Figure 1 The IFR positions and their occupancy by amino acids shown for 70 serine proteases bound to BPTI. The rows show amino
acids occupying IFR positions for specific serine protease (the PDB ID given in the second column). The top row shows the sequence numbers
in structurally aligned serine proteases (only IFRs are listed) for all enzymes in complex with the BPTI. The complexes were created by the
procedure we named “hard docking”, except for the case of 1fy8.pdb for which we have experimental data (row marked with light gray
background). The color code for amino acids is as follows: Residues: AVLIMFP are colored grey [containing: small hydrophobic residues (A and
P) and large hydrophobic residues]; Residues: STYNQWG are colored green [containing: polar residues]; Residues: D and E are colored red
[containing: negatively charged residues]; Residues: R and K are colored blue [containing: positively charged residues]; Residue: H is colored cyan
[containing: positively charged residue which is neutral at neutral pH]; Residue: C is colored yellow [containing: disulphide bridge forming
residue]. {See text for details about amino acid classification} The rows are occupied by following serine protease sub-families: Tryptase(1-2),
Chymase (3-4), Chymotrypsin (5-8) {red background}, Elastase (9-13){blue background}, Exfoliative toxin (14-15), Glutamyl endopeptidase (16-18),
Kallikrein (19-22), NS3 protease (23-25), Streptogrisin (26-27), Trypsin (28-36){green background}, Venom (37-38), Thrombin (39-43){yellow
background}, Miscellaneous-Prokaryotes (44-48), Miscellaneous-Virus (49-50), Miscellaneous (51-67), Native Complex (68-70) in respective row
order.
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Page 4 of 16(ref: http://www.gbiosciences.com/ResearchProducts/
Aprotinin.aspx). On the other side, turkey ovomucoid
third domain was reported to interact with very similar
association constant with eight different serine protei-
nases-bovine chymotrypsins A and B, porcine pancreatic
elastase I, proteinase K, Streptomyces griseus protei-
nases A and B, and subtilisin-Carlsberg [20]. Pál et al.
[21] reported the following Ki (M) values for ecotine
against trypsin, chymotrypsin and elastase, respectively:
1×1 0
-12, 4 × 10-
12 and 1.3 × 10
-9.
Figure 2 An extract from all IFR positions showing the most restrictive ones, identified for four serine proteases subfamilies, bound to
BPTI. The positions shown are among the most restrictive ones in terms of the type of residues occupying them in 4 sub families of serine
proteases: trypsins; chymotrypsins; elastases and thrombins, respectively. Those residue types that are present in at least 50% or more of
analyzed proteases within a single subfamily, at a given IFR position, are indicated by a ‘*’ sign. The colors of residues correspond to STING AA
color coding {see text for details as well as the legend for the Table 1}: green are Polar, gray are Hydrophobic, red are negatively Charged, blue
(and cyan for His) are positively Charged residues. The gray background color is used to indicate those IFR positions which are populated, within
a sub family, by a single residue type or are absent from the IFR ensemble (represented by “-”). Those IFR positions occupied in each of four sub
families by one predominant class of amino acid (indicated by “*”) are labeled in light gray.
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Page 5 of 16Amino acid composition at serine protease interfaces
Additionally, the difference between the polarity and
hydrophobicity of the enzyme surface and interface was
investigated for each in silico complex formed. The bur-
ied area and total enzyme free surface area (not including
the interface) was compared with respect to the type of
residues present. Again, the following residue classes
were used: charged, hydrophobic and polar (with glycine
considered separately, although being classified as a polar
residue). The data presented in Figure 5 indicate that
most interfaces, in all serine protease subfamilies bound
to either BPTI, ecotine or ovomucoid third domain, have
a general preference for polar residues (green and gray
bars). Conversely, most of free enzyme surfaces (not
including interface/buried area) show a preference for
charged residues (blue bars) although some (7 out of 16)
also do show a smaller (as compared to a preference for
charged residues) preference for hydrophobic residues
(red bars).
Some subfamilies do not follow these patterns. The
interface of the streptogrisin subfamily shows a high
presence of glycine residues for complexes with each of
the three inhibitors (negative gray bars in Figure 5),
while the rest of the surface shows preference for polar
Figure 3 An extract from all IFR positions, identified for four serine proteases subfamilies, bound to Ecotine.S h o w np o s i t i o n sa r e
designated in a same form as in the Figure 2 above.
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Page 6 of 16residues (green bars). Elastase shows the lowest differ-
ences among interface and surface preferences for 4
classes of amino acids defined in this work. Charged
residues were found to be uniquely prevalent at the
interfaces between the “miscellaneous-virus” subfamily
and the three inhibitors. This prompts speculation
about how important this difference in IFR characteris-
tics is for maintaining virulence of those organisms. The
upper part of the Figure 5 shows a strong presence of
hydrophobic residues at the interfaces (together with
polar residues including glycine), while the bottom part
of the Figure 5 shows an absence (except for the 3
experimental complexes) of the hydrophobic residues at
the interface (left portion of this graph). The bottom
part of the Figure 5 shows an increase in the presence
of hydrophobic residues at the free enzyme surface area.
The surfaces (not including interface areas) have a pre-
valence of charged residues while the interface contains
more polar (including glycine) residues (with some
exceptions as described above). Thus, the IFR pocket of
serine proteases is not formed by predominantly hydro-
phobic residues; it is a rather polar environment. Also,
Figure 4 An extract from all IFR positions, identified for four serine protease subfamilies bound to Ovomucoid third domain.S h o w n
positions are designated in a same form as in the Figure 2 and 3 above.
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Page 7 of 16the interface contains much fewer (with one exception
being “miscellaneous-virus”) charged residues (as com-
pared to the rest of the protease surface).
If our data are compared with the ones from Janin
et. al. [22], one can observe that the serine proteases are
endowed with a specific category of interfaces in terms
of the contribution of the 20 amino acids types to that
area: subfamilies vary in the contribution of hydrophobic
residues and are almost constant in having a lower pre-
ference for the charged residues, as presented at the
Figure 5 Difference of residue class occupancy in total enzyme free surface vs. interface. This Figure presents the difference in occupancy
percentage of total enzyme free surface and the IFR area for all 70 serine proteases bound to the inhibitor Ecotine, BPTI and Ovomucoid third
domain. The enzymes were classified in the following subfamilies: Tryptase (2), Chymase (2), Chymotrypsin (4), Elastase (5), Exfoliative Toxin (2),
Glutamyl endopeptidase (3), Kallikrein (4), NS3 protease (3), Streptogrisin (2), Trypsin (9), Venom (2), Thrombin (5), Miscellaneous-Prokaryotes (5),
Miscellaneous-Virus (2), some variety of serine proteases not belonging to any of above defined subfamilies (Miscellaneous, 17) and experimental
complex (3). Average values of percent occupancy are presented for multi-member subfamilies. The numbers between the brackets show the
number of enzymes in each subclass. Bars on the left side of the graph indicate that that particular residue class is more frequently found at the
interface than at the surface. Bars on the right side of the graph indicate that the residues are more frequently found at the surface than on the
interface.
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Page 8 of 16Table 2. These results point to the fact that although all
four serine protease subfamilies do not show a great
variability with respect to the percentage of the enzyme
total surface area being buried upon in silico complex
formation with the BPTI, ecotine and ovomucoid third
domain (6.7%, 9.5% and 7.2% respectively, representing
value of approximately 610 to 990 Å
2 of buried area),
the percentage of the residue classes contributing to the
interface varies significantly. The percentage that
charged and polar residues contribute together to the
total buried area in trypsin/BPTI is 86%, in chymotryp-
sin/BPTI is 65%, in elastase/BPTI is 75%, and for throm-
bin/BPTI is 84%. For all three inhibitors examined,
thrombin and trypsin have the highest percentage of
charged and polar residues contributing to buried area
w h i l ee l a s t a s ea n dc h y m o t r y p s i nh a v et h el o w e s t .T h e
details for the difference in occupancies are presented in
Figure 5 and Table 2.
T h o s ed i f f e r e n c e sm a yb ea l i g n e dw i t ht h ec o r r e -
sponding function that each protease performs. How-
ever, it is important to realize the boundaries we should
not cross when applying what we have learned here
based on inhibitor-protease binary complexes to sub-
strate-protease complexes. Nevertheless, we assume that
inhibitors of serine proteases bind to the active site
clefts of their target proteases in a manner that is
thought to resemble the binding mode of substrates
(Laskowski et al. [23]). Trypsin and thrombin handle the
positive charges of a polypeptide by imposing the (com-
plementary) charge/polarity of their own IFR surface.
Chymotrypsin mitigates the spatial constraints imparted
by large hydrophobic (and some polar) residues present
in the substrate/inhibitor by accommodating glycines
and hydrophobic residues into its own interface. Elas-
tases, on the other hand, utilize hydrophobic amino
acids among their IFRs to complement small, hydropho-
bic amino acids at the cleavage site of a polypeptide.
The general trends for interfaces described above, when
combined with the selectivity of IFR positions discussed
earlier in this section, provide a more complete descrip-
tion of the specificity of serine protease subfamilies in
both general and detailed way, although, as we expected
from the beginning, there is no canonical code that we
may convey from this analysis.
Benchmarking the accuracy of the “hard docking”
procedure for IFR identification
The “confusion matrix” presented at the Table 3 con-
tains 5 categories of evaluators for IFR identification.
The true positives (TP) are IFR residues present in both
t h en a t i v ea n dt h er i g i db o d yd o c k e dc o m p l e x e s .T h e
true negatives (TN) are solvent exposed residues both in
native and in in silico complexes. The false positives
(FP) are residues present in the rigid body docked IFR
table but absent in natural complexes and the false
negatives (FN) are not buried in native complexes but
appear in the IFR of the in silico complexes. The accu-
racy was calculated based on this formula: ACC =( TP +
TN)/(P + N), where the P = (TP+FN) and N = (FP
+TN). Table 3 shows these values for 1FY8 (control)
Table 2 The percent of the total enzyme buried area occupied by amino acid sub-classes
Inhibitor bound to
serine proteases
[%] Hydrophobic
residues in buried area
[%] Charged
residues in buried
area
[%] Polar residues at
buried area (glycine %)
[%] (Charged + Polar)
residues in buried area
BPTI Trypsin (9) 14 10 76 (10) 86
Chymotrypsin
(4)
35 11 54 (8) 65
Elastase (5) 25 21 54 (6) 75
Thrombins (5) 16 37 47 (6) 84
Ecotine Trypsin (9) 13 15 72 (10) 87
Chymotrypsin
(4)
30 18 52 (6) 70
Elastase (5) 22 19 59 (9) 78
Thrombins (5) 12 53 35 (6) 88
Ovomucoid Third
domain
Trypsin (9) 12 10 78 (11) 88
Chymotrypsin
(4)
32 10 58 (9) 68
Elastase (5) 24 20 56 (9) 86
Thrombins (5) 15 37 48 (7) 85
The serine proteases are bound to BPTI, ecotine and ovomucoid third domain inhibitors. Areas occupied by the three classes of amino acids, with respectt ot h e
total buried enzyme area, are expressed as a percentage. The numbers between the brackets show the number of enzyme - inhibitor complexes included in this
analysis for each subfamily. The column containing polar residue participation also contains (within brackets) the participation of glycine residues.
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Page 9 of 16and the sixteen complementary complexes. Overall, the
accuracy (ACC) ranged between 0.97 and 0.98.
Evaluation of plausibility for in silico generated bi-
molecular complexes
T h ep r e s e n c eo fs t e r i cc l a shes involving enzyme and
inhibitor residues was analyzed to evaluate our hard
docking methodology. Steric clashes could yield unfa-
vourable interactions within complexes that would lead
to their decreased stability which might be translated to
their faster de complexation in vivo.
We calculated the distances between enzyme and inhi-
bitor residues at the interface for BPTI (Figure 6A), eco-
tine (Figure 6B) and ovomucoid third domain
complexes with serine proteases (Figure 6C). All 70 ser-
ine proteases are presented using the same numbering
(x-axis) as in Table 1, and the same subfamily grouping
(colored symbols follow the colors of subfamilies as in
Figures 2, 3 and 4). The y-axis shows the distances,
measured in Ångstroms, with bars indicating a corre-
sponding standard deviation for each point. The dis-
tances are the average values obtained by calculating the
sum of the CA-CA (Alpha Carbons) distances for each
amino acid belonging to the IFR ensemble from the
enzyme side, to the closest amino acid from the IFR of
the inhibitor, and then divided by the number of IFR
residues at the enzyme site. A horizontal line represents
the average global mean which was always near 7.0 Å
for all three types of inhibitor complexes. In a prior
Table 3 Evaluation of the success rate (ACC) of predicting
IFR ensemble
PDB
ID
Subfamily Organism TP TN FP FN ACC
1FY8 Trypsin Bos taurus 44 244 0 0 1
3TGI Trypsin Bos taurus 42 239 5 0 0.98
1TPA Trypsin Bos taurus 44 240 1 3 0.98
3BTK Trypsin Bos taurus 43 241 1 4 0.98
3TPI Trypsin Bos taurus 43 242 1 2 0.98
2PTC Trypsin Bos taurus 44 241 0 3 0.98
2TGP Trypsin Bos taurus 45 240 0 3 0.98
4TPI Trypsin Bos taurus 44 239 1 4 0.98
2TPI Trypsin Bos taurus 44 241 1 2 0.98
1BZX Trypsin Bos taurus 43 242 2 1 0.98
1BRB Trypsin Rattus
novergicus
41 236 2 2 0.98
1FAK Coagulation factor
VIII
Homo sapiens 44 247 6 0 0.97
1CBW Chymotrypsin Bos taurus 44 238 5 1 0.97
1MTN Chymotrypsin Bos taurus 45 239 1 3 0.98
2KAI Kallikrein Bos taurus 57 224 0 4 0.98
1EAW Matriptase MTSP1 Homo sapiens 42 241 4 1 0.98
The true positives (TP) are IFR residues present in both the native and the
rigid body docked complexes. The true negatives (TN) are solvent exposed
residues both in native and in in silico complexes. The false positives (FP) are
present in the rigid body docked IFR but absent in natural complexes, and
the false negatives (FN) are not buried in native complexes but appear in the
IFR in generated in silico complexes.
Figure 6 Proximity of IFRs belonging to residues from 70
serine proteases to the closest IFR residues belonging to
Ecotine (A), BPTI (B) and Ovomucoid third domain (C). Each
point in the graph represents the mean and the standard error of
the mean for the smaller distances encountered for each IFR
residue of the enzyme to the closest IFR residue of the inhibitor.
The horizontal line is representing the global average value for the
measured distances.
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Page 10 of 16paper [24], our research group demonstrated that 7.0 Å
is the cut-off distance that optimizes the isolation, at the
residue level, of first order of contacts (first coordination
shell) in well-packed globular proteins. The observed
7.0 Å average global mean distance among CAs in
enzyme-inhibitor complexesc o n f i r m st h a ti n h i b i t o r s
and enzymes form well-packed complexes like those
found in the core of globular proteins. Thus, it is plausi-
ble to conclude that complexes which present distances
less than the average global mean contain spatial
clashes. Those complexes can be further submitted to
dynamics and minimization in order to rearrange these
residues and diminish the steric clashes. We are set up
to try to evaluate how many and which steric clashes
would be removed by such procedure, however, this is
yet to be done as a next step of our project.
Discussion
The data collected, analyzed and presented in this work
serves as a tool for understanding binding properties in
general and protease specificity in particular, based on
Interface Forming Residue (IFR) profile alignment.
The procedure we have developed for this work
describes a): the ensemble of IFRs for any complex
formed between a serine protease and an inhibitor and
b): the differences in interface characteristics between
various proteases with respect to specificity. From our
d a t ao n em a yn o te x t r a c tas i m p l e ,c o n c i s ea n dv e r y
straightforward rule for separation among proteases in
terms of specificity (defined here mainly by IFR position
occupancy and characteristics). Nature obviously pre-
pared a mechanism for fine tuning of the activity that
yields terms of specificity for each subfamily of serine
proteases. There is obviously some space left for overlaps
among IFR characteristics and positions that dictate the
specificity for each sub family and consequently, what
could have been a simple table with reduced complexity
in terms of “colors” and characteristics of amino acids
employed at each IFR position, became somewhat
blurred. The data presented here are precise in pointing
to such granular/spectral distribution in IFR occupancy
that would be directly coupled to the specificity type of
studied enzymes. It is our perception that the beauty of
the adaptability of molecular mechanisms, expressed here
in form of their specificity, can still be presented in a
such simplified way (described in Figures 1 to 4) showing
how specificity can be fine-tuned from different points of
entry (multiple, rather than single): IFR positions and
characteristics of amino acids that occupy those critical
positions. The procedure we described may also open the
possibility to yield some details that may account for dif-
ferences in how strong might be the binding between an
enzyme and an inhibitor (an issue we need to explore in
the future with more details based on elaborated IFR
tables and experimental data available in literature).
It has been established that increased structural plasti-
city in the binding pocket increases the variation of sub-
strate size that can fit into the critical space directed
toward the catalytic triad which correspondingly
decreases the specificity [25]. Consequently, it is
expected that the higher the stiffness around the binding
pocket, the higher the selective pressure will be on a
particular substrate. Specificity then can be seen as
directly proportional to structural limitations imposed
f i r s tb yt h es i z eo ft h ed o c k i n gs p a c ea n dt h e nb yt h e
physical and chemical characteristics of this space. By
focusing our attention on the type of residues occupying
the enzyme and inhibitor interfaces, we have set aside
the evaluation of how plasticity of binding pocket influ-
ences enzyme specificity. This factor, however, is not
taken as a non important one. In fact, we will be under-
taking further examination in order to understand better
how plasticity may be accounted for by IFR properties -
therefore we will be tackling this task in the future. As a
start, the residue types occupying the interface positions
implicitly contain the sort of information which relates
directly to plasticity of the site.
Conclusions
The work presented here offers insight into the struc-
ture/function relationship of serine proteases. The
superposition of structurally aligned backbones of serine
proteases showed that they use essentially identical scaf-
folding and achieve a variety of specificities by varying
surface residues. Previously, there have been attempts to
modify the functionality of serine proteases. These
attempts usually focus on several residues and generally
result in the loss of enzyme activity. Our approach
explains why and corroborates with the results pre-
sented by Ma et al. [26] and Novozymes Biotech, Inc.
(Davis, CA, US) which patented a technology (Microbial
trypsin mutants having chymotrypsin activity - United
States Patent 20050037368) by confirming necessity for
several IFR amino acids to be either substituted, or
deleted ("no-show” event) or to be introduced in original
protease sequence in order to transform trypsin to
chymotrypsin.
Based on the results we are reporting here, we are
poised to assemble, in the near future, the serine pro-
tease superfamily interface data resource as an expand-
ing collection of sequence, structural, and functional
information about the serine proteases interface forming
residues. A combination of graphics, images and numer-
ical data will be used to aid in the complete analysis of
structure/function relationships that still require our
attention before we may fully understand the precise
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Page 11 of 16role of each amino acid employed at the particular loca-
tion by enzymes in order to achieve desired specificity.
Methods
In order to provide a sufficient volume of data for
analysis of the interfaces around active sites of serine
proteases (even if there is no currently available infor-
mation on complex formation of one particular pro-
tease with any specific substrate and/or inhibitor) we
needed to employ the in silico approach for building
corresponding complexes. The key feature of our work
is mapping the IFR 3D profile into a 2D matrix–from
a known enzyme-inhibitor structure to those with no
known structure for such complex. Mapping is done
after structurally aligning all serine proteases with
non-redundant sequences.
Selection of serine protease: structural data set
The PDB IDs for serine proteases were obtained from
SCOP database [27] parseable files (release 1.73). All
1086 PDB IDs from family b.47 were selected. FASTA
files relative to these IDs were obtained in the PDB. A
BLAST search (blastp), using default parameters, was
run to determine the percentage of identity between the
selected sequences. Those sequences with lower than
95% identity were selected for further examination
(meaning that there should be at least 12 to 15 different
residues occupying corresponding positions among
selected sequences. In general, the sequences are 240 to
260 amino acids long, which means that applied filtering
eliminates structures obtained after single, or even after
limited multiple, point mutations). From the resulting
subset (which we named here as the “primary data-
mart”), further selection eliminated all but those struc-
tures showing the highest resolution (lower numerical
values in Å) and best R-value. This yielded what we
named as a “secondary datamart”.T h e“secondary data-
mart” at this point contains 67 serine proteases. Those
structures covered the following sub families: tryptase,
chymase, chymotrypsins, elastase, exfoliative toxin, glu-
tamyl endopeptidase, kallikrein, NS3 protease, strepto-
g r i s i n ,t r y p s i n ,v e n o m ,t h r ombin, serine proteases from
prokaryotes (which we named as “miscellaneous-prokar-
yotes”), serine proteases from viruses (which we called
“miscellaneous-virus”) and serine proteases that do not
fit any of the mentioned sub families which we called
“miscellaneous”. The above described division resulted
in 15 “sub-families” on which we applied additional
manual inspection (in order to re-confirm their classifi-
cation) by consulting the following sources: PDBsum
[28], BRENDA [29] and SCOP parseable files.
The list of all corresponding PDB IDs for serine pro-
teases used in this work is presented in the Table 1.
Selection of experimentally described enzyme/inhibitor
structural complexes
From the 57 available PDB files containing inhibitor/ser-
ine protease complexes (data from January 2009), com-
prising 11 SCOP inhibitor families, the three largest
families were selected and the same approach as
described above was followed to select for what we
named here as the three “prototype complexes”.C o m -
plexes containing BPTI, ecotin and ovomucoid inhibi-
tors correspond respectively to g.8, b.16 and g.68 SCOP
subfamilies and are represented, respectively, by 1FY8
(inhibiting rat trypsin), 1AZZ (inhibiting crab collage-
nase) and 1CHO (inhibiting cattle alpha-chymotrypsin)
PDB files. We named this group as “prototype com-
plexes” because they represent the experimentally
described complexes with structures deposited into the
PDB.
Structural alignment
Before the alignment procedure took place, we needed
t oe d i tt h eP D Bf i l e s .T h e1 C H O . P D Bf i l ew a se d i t e dt o
replace the three enzyme chain IDs (E, F, G) with a sin-
gle “chain E”. This was done in order to easily distin-
guish the enzyme chains from the inhibitor chain
named “I”. For the 1AZZ file, containing two chains,
only chain A (enzyme) and chain C (inhibitor) were
used (the PDB file contains a description of a hetero-
dimer). The 1FY8 was not edited before further proces-
s i n g .I no r d e rt oo b t a i na nI F Re n s e m b l ef o rt h es e r i n e
proteases lacking an available structure for the complex
with chosen inhibitor (or any inhibitor at all), we first
structurally aligned all 70 selected serine proteases (67
from the “secondary datamart” plus 3 serine proteases
from the “prototype complexes”)u s i n gP r I S M[ 3 0 ]a n d
its set of default parameters, http://wiki.c2b2.columbia.
edu/honiglab_public/index.php/Software:PrISM. The
PrISM software also provided a multiple sequence align-
ment (being generated as an output obeying the struc-
tural alignment), which was saved and parsed to
preserve both residue numbering and residue positions
occupied in the structural alignment.
Rigid body docking
The term “rigid body docking” is used here to describe
what was done in order to get complexes of each of the
67 serine protease structures bound to 3 different inhibi-
tors. Effectively what we did was added the inhibitor
coordinates to each PDB file from the “secondary data-
mart”. In order to do so, we first needed to guarantee
that the inhibitor molecule would be added to any of the
enzyme molecules in exactly the same fashion as it did in
the “prototype complex”. This guarantee was provided by
aligning a pair of structures where the first was the
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(e.g. 1FY8) and the second was from the PrISM output
file - one of the 70 structurally aligned enzymes (e.g.
1FY8_PrISM). This additional structural alignment was
performed with PyMOL [31] software, using the com-
mand line “align (1FY8, 1FY8_PrISM)”, which maintained
the PrISM generated coordinates of the 1FY8_PrISM
structure and superimposed the enzyme coordinates
from a selected “prototype complex”. Consequently, this
procedure also relocated the inhibitor coordinates from
the “prototype complex”. The newly obtained coordinates
for the inhibitor were then extracted from the PyMOL
output (PDB formatted) file and used to edit the PrISM
output file for the other 69 serine proteases. By doing so,
we included the inhibitor coordinates now fitting to a
selected enzyme in a position exactly equivalent to the
one that the inhibitor assumed in the “prototype com-
plex”. The three sets (each containing 70 complexes)
were therefore formed. Thed e t a i l so ft h ep r o c e d u r e
described above are illustrated in Figures 7, 8 and 9.
Upon completing the procedure, all structures containing
a complex between a serine protease (one of 70 of them)
and an inhibitor (one of the three selected ones) could be
described as spatially oriented in a consistent and unique
manner (obeying structural alignment) and having the
inhibitor in a position consistent with the one observed
and described experimentally.
A st h ep r i m a r yp u r p o s ew a st od e l i n e a t eag e n e r a l
area defined as an interface, additional precision, as
obtained by minimization and dynamics procedures
(generally applied to remove space-clashes), was not
considered critical and therefore not applied in this
stage of the work. It is important to note that many
complexes are in fact “forced” to be formed in silico by
a “rigid body docking” procedure, but due to various
factors, including insufficient shape complementary
between the inhibitor side and corresponding binding
pocket on the enzyme side, they would form with a cer-
tain degree of instability and would therefore be short
lived. A qualitative description of this scenario is
described in Figure 9 (also see Figure 6. for an estimate
of the degree of space clashing among enzymes and
inhibitors in all in silico formed complexes).
Surface determination in rigid body docked complexes
The three sets of 70 enzyme-inhibitor complex struc-
tures were also studied with respect to solvent accessi-
bility of surface amino acids (calculated both before and
upon inhibitor binding). The change in solvent accessi-
bility of surface amino acids for both inhibitor and
enzyme (in isolation and upon binding) was calculated
by the Surfv algorithm [18]. Residues with a change in
solvent accessibility were compiled into the ensemble of
IFRs.
Interface Forming Residues Table
For each set of 70 complexes, we mapped all of the
sequence positions that belonged to the IFR ensemble
(table shown at Figure 1). We took the native trypsin-
BPTI complex (1FY8) as a reference for sequence num-
bering because it follows standard serine protease
sequence numbering. All residues showing a detectable
loss of accessible area were labeled in the multiple struc-
ture-based sequence alignment obtained with PrISM
according to the residue positions in the sequence of
1FY8 chain E. In the case of gap in the reference
sequence, a letter was added to the previous number
(designating the position of the particular amino acid in
a given sequence), so that the label keeps following the
reference sequence numbering. Columns without at
least one residue labeled as an IFR were eliminated to
facilitate the analysis. For the case of BPTI, 36 residues
occupying IFR positions were compiled (table shown at
Figure 2) and ranged from positions 37 to 228 (also see
Figure 1). Corresponding numbers for the ecotine and
ovomucoid third domain are 40 IFRs from 37 to 226
and 34 IFRs from 37 to 217A, respectively. The multiple
alignment of IFRs for the 70 serine proteases complexed
with BPTI is presented in the Figure 1 (the correspond-
ing tabular data for ecotine and ovomucoid inhibitor are
not shown here). The derivatives from the tables with
70 serine proteases bound to BPTI, ecotine, and ovomu-
coid third domain are presented in the tables shown at
Figures 2, 3 and 4; there we have only those columns
Figure 7 Structural alignment of 70 different (sequence-wise
non redundant) serine proteases aligned by PrISM package.
The image was produced using PyMOL. Only the main chain is
represented. The following positions in chymotrypsinogen are
highlighted: Ser 195 in green, His 57 in red and Asp 102 in blue.
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Page 13 of 16which had some prevalent residues occupying that spe-
cific position. Particular differences among 4 principal
classes of serine proteases were aimed. In other words,
some positions were eliminated as they had a same resi-
due present in each of the four sub-families of serine
proteases (such as the position of HIS 57 which does
not contribute to differentiation among 4 subfamilies).
Those positions which were not identified as an IFR for
the particular pair of serine protease and inhibitor are
presented by a “-” sign. It is important to mention that
the Asp_102 is not seen in Figure 1 due to a very pecu-
liar characteristic of the catalytic pocket (as explained
previously in the “Background” session).
O n c ew ec o n s t r u c t e dt h e3s e t so f7 0c o m p l e x e so f
proteases with respective inhibitors, we made an inquiry
into the relationships between structural characteristics
and specificity of enzymes. We calculated the difference
in residue type occupancy of the total enzyme surface
and the respective interfaces. The goal was to find if the
interface was different from the rest of the protein sur-
face in terms of types of residues present. Using the
Surfv algorithm, we calculated the total enzyme surface
Figure 8 Hard docking of inhibitor coordinates to selected serine proteases. (a) Schematic diagram of the experiment for obtaining the
structure of three different sets of 70 serine proteases with each one of the three selected inhibitors: Ecotine (green), BPTI (blue) and
Ovomucoid third domain (light gray). The arrows placed below each of the three sets of 70 structurally aligned serine proteases are indicating
that only one structure had experimental coordinates for both the serine protease and its corresponding inhibitor (indicated by the
corresponding color). All the other proteases “received” that inhibitor in a position identical to the one found in the experimentally determined
enzyme/inhibitor complex (one of three “prototype complexes”). From each obtained set, the IFR ensemble was extracted and analyzed; (b)
structure of the BPTI/protease complex as found in 1FY8.pdb; (c) BPTI is “rigid body docked” into the complementary 70 structurally aligned
serine proteases. One of those 70 enzyme structures is identical to the one presented in (b).
Figure 9 Qualitative evaluation of the space fit between
inhibitor and serine proteases. The first set of complexes
obtained as described in Figure. 6 above was de-convoluted in
order to schematically demonstrate space compatibility of the BPTI
inhibitor and the binding pocket of the complementary 70 different
proteases. The “+"and “-” signs were manually introduced to
qualitatively “quantify” visual complementarity of the surfaces of the
inhibitor and corresponding binding pocket. We used those
structures to exclusively identify the IFRs, not to evaluate the
binding compatibility.
Ribeiro et al. BMC Structural Biology 2010, 10:36
http://www.biomedcentral.com/1472-6807/10/36
Page 14 of 16area and determined the fraction occupied by each of
four classes of amino acids. The same procedure was
applied for the IFR area. Amino acid classes are as indi-
cated: Charged, Polar, Hydrophobic and Glycine (a sin-
gle member sub group of polar). The results of this
inquiry are shown in Figure 5, as well as tabulated in
the Table 2, and are discussed in more detail in results
and discussion sections.
Amino acid classification and color coding
Before we can discuss our findings, it is necessary to
explain the founding principles for amino acid classifica-
tion (and their color coding) that we adopted for this
work. In this paper we decided to pay special attention
to three amino acid classes (hydrophobic, polar and
charged) and also to treat, in a separate way, the three
amino acids G, C and H.I nt h ec a s eo fGly,i t so c c a -
sionally given separate consideration because of its
peculiarity: Gly has one hydrogen atom instead of the
side chain (in a sense, Gly residues received an indivi-
dual treatment here just as in the Ramachandran plot
[32], for example). In case of the Cys, special treatment
is given because it is the only residue that forms disul-
fide bridges. Lastly, H i si st r e a t e ds e p a r a t e l ybecause
this residue is “neutral polar” at physiological pH but
positively charged when protonated.
The amino acid color code is an adaptation of “amino-
chromography” suggested by William Taylor [33]. Resi-
dues AVLIMFP are colored grey (small hydrophobic [A
and P]) and also large hydrophobic [VLIMF]). Residues
STYNQWG are colored green (polar - we are including
Y and W to this ensemble although both residues have
aromatic rings: phenol and indole, respectively). Those
aromatic rings are often considered as another impor-
tant feature for Y and W - the source of their hydro-
phobicity. The hydrophobic character of W and Y is
often imposed above their polar characteristics. How-
ever, we consider W as an ambivalent residue (polar
and hydrophobic) and Y as a polar residue. Residues D
and E are colored red (negatively charged). Residues R
and K are colored blue (positively charged). Residue C
is colored yellow (disulphide bridge forming), and resi-
due H [positively charged but neutral at neutral pH] is
coloured cyan (light-blue).
The classification of amino acids follows the scheme
given in “Structural Bioinformatics”,p a g e1 8[ 3 4 ]a n di s
supported by hydrophobicity scales by Janin [35], Kyte
and Doolitle [36] and Rose [37]. It is known that some
of the hydrophobicity tables cited here (and in other
papers found in general literature) present an apparent
contradiction with respect to classification of certain
amino acids. For example G and W are often a subject
of controversy in terms of being considered polar or
hydrophobic. We needed to decide which option to use
in our paper, and the preceding description defines
which one we opted for. It is clear therefore that an
alternative classification is also possible although, we
would consider it less precise.
Validation of Methodology
To validate our methodology for defining IFRs through
“hard docking”, we selected 16 native complexes (not pre-
sent in the “secondary datamart”) of serine proteases
bound to BPTI–the inhibitor with the largest number of
native complexes available in the PDB (Table 3 lists the
PDB IDs of the selected complexes). We investigated how
successful our methodology was at predicting IFR residues.
Namely, by using the 1FY8 complex as a reference and
transferring the inhibitor coordinates to the enzyme chains
of the sixteen complexes, we compared real IFRs and ones
obtained by rigid body docking. This was done by aligning
the enzyme chains of the sixteen complexes using PyMOL
and rigid body docking the inhibitor of 1FY8. The docking
results were then compared to those reported for native
bound inhibitors. Afterwards, we used the Surfv algorithm
to determine the residues composing the interface (IFR) of
the sixteen in silico complexes.T h es a m ea l g o r i t h mw a s
used to determine the IFRs in the respective native com-
plexes. A comparison between rigid body docking and
native IFR in natural complexes was then possible. From
these results, a “confusion matrix” [38] was generated.
Detailed analysis of corresponding data is given in results
and discussion sections.
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